Next, to assess whether ST6GALNAC3 and ZNF660 promoter methylation levels in PC tissue samples could be associated with tumor aggressiveness, we evaluated possible associations between promoter methylation levels and standard clinicopathological prognostic variables. Here, ZNF660 is linked to neoplasm.